Company release
The Annual General Meeting of
Use of profit shown on the balance sheet and the payment of dividend
The General Meeting resolved that based on the balance sheet adopted for the financial period of 1 July 2022-30 June 2023, no dividend is paid, and that the loss of the financial period is recorded in retained earnings.
Board of Directors
The number of members of the Board of Directors was confirmed to be six (6).
The General Meeting resolved that the members of the Board of Directors are paid a monthly remuneration of
Auditor
Authorized Public Accounting firm
Authorizing the Board of Directors to decide on the repurchase of company's own shares
The General Meeting authorized the Board of Directors to decide on the repurchase of the company's own shares on the following terms and conditions:
By virtue of the authorization, the Board of Directors is entitled to repurchase a maximum of 2,058,592 A-series shares and 3,915,397 B-series shares by using the non-restricted equity of the company. The shares may be repurchased in one or more lots.
The company's own shares shall be repurchased at the market price prevailing at the time of the repurchase through public trading on Nasdaq First North Growth Market Finland marketplace organized by
The shares may be repurchased to be used in the implementation of possible acquisitions or other arrangements within the company's business, to finance investments, to develop the company's financial structure, as part of the implementation of possible incentive schemes of the company and/or otherwise to be kept by the company, transferred or cancelled.
The authorization includes the right of the Board of Directors to decide on other terms and conditions related to the repurchase of the company's own shares. The authorization is valid for 18 months. The authorization revokes the authorization to repurchase the company's own shares decided by the previous Annual General Meeting on
Authorizing the Board of Directors to decide on the share issue and granting of special rights entitling to shares
The General Meeting authorized the Board of Directors to decide on issuing new shares, conveying the company's own shares held by the company and/or granting of special rights referred to in Chapter 10, Section 1 of the Companies Act on the following terms and conditions:
Maximum amount of shares to be issued
By virtue of the authorization, the Board of Directors is entitled to issue and/or convey a maximum of 594,992 A-series shares under one or more decisions. The share issue and shares granted under the special rights are included in the specified maximum amount.
In addition, by virtue of the authorization, the Board of Directors is entitled to convey a maximum of 577,920 EMP-series shares held by the company under one or more decisions.
The authorization does not apply to the company's B-series shares.
The authorization now granted revokes the authorization decided by the Annual General Meeting on
The authorization now granted does not revoke or change the authorization resolved at the Extraordinary General Meeting held on
Other conditions
The shares may be issued either against payment or without payment and they may also be issued to the company itself. The authorization entitles the Board of Directors to implement the share issue also as a directed issue. The authorization may be used in the implementation of possible acquisitions or other arrangements within the company's business, to finance investments, to develop the company's financial structure, as part of the implementation of possible incentive schemes of the company and/or for other purposes decided by the Board of Directors.
The authorization includes the right of Board of Directors to decide on other terms and conditions of the share issue and granting of special rights referred to in Chapter 10, Section 1 of the Companies Act. The authorization is valid for 18 months.
Publication of the minutes
The minutes of the Annual General Meeting will be available on the company's website on
Resolutions of the Board of Directors of
In the organizational meeting held after the Annual General Meeting, the Board of Directors elected
For further information:
CEO
Certified Adviser:
About
https://news.cision.com/nightingale-health/r/resolutions-of-the-annual-general-meeting-and-the-board-of-directors--organizational-meeting-of-nigh,c3877600
(c) 2023 Cision. All rights reserved., source